First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid

被引：61

作者：

Cho, Y. T.

Chu, C. Y.

Wang, L. F. ^{[1
]}

机构：

[1] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei 10002, Taiwan

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2015年 / 173卷 / 01期

关键词：

MORTALITY;

D O I：

10.1111/bjd.13633

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100227 [皮肤病学];

摘要：

引用

收藏

页码：302 / 304

页数：3

相关论文

共 9 条

[1]

Specific causes of death in patients with bullous pemphigoid as measured by death certificate data: a retrospective cohort study [J].

Barrick, Benjamin J. ;

Lohse, Christine M. ;

Lehman, Julia S. .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2015, 54 (01) :56-61

[2]

Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre [J].

Cai, S. C. S. ;

Allen, J. C. ;

Lim, Y. L. ;

Chua, S. H. ;

Tan, S. H. ;

Tang, M. B. Y. .

BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (06) :1319-1326

[3]

First-line Combination Therapy with Rituximab and Corticosteroids is Effective and Safe for Pemphigus [J].

Cho, Yung-Tsu ;

Lee, Fang-Yu ;

Chu, Chia-Yu ;

Wang, Li-Fang .

ACTA DERMATO-VENEREOLOGICA, 2014, 94 (04) :472-473

[4]

Incidence and Mortality of Bullous Pemphigoid in France [J].

Joly, Pascal ;

Baricault, Sophie ;

Sparsa, Agnes ;

Bernard, Philippe ;

Bedane, Christophe ;

Duvert-Lehembre, Sophie ;

Courville, Philippe ;

Bravard, Pierre ;

Remond, Brigitte ;

Doffoel-Hantz, Valerie ;

Benichou, Jacques .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (08) :1998-2004

[5]

Rituximab for treatment-refractory pemphigus and pemphigoid: A case series of 17 patients [J].

Kasperkiewicz, Michael ;

Shimanovich, Iakov ;

Ludwig, Ralf J. ;

Rose, Christian ;

Zillikens, Detlef ;

Schmidt, Enno .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 65 (03) :552-558

[6]

Mortality of Bullous Pemphigoid in China [J].

Li, Jun ;

Zuo, Ya-Gang ;

Zheng, He-Yi .

JAMA DERMATOLOGY, 2013, 149 (01) :106-108

[7]

Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients [J].

Lourari, S. ;

Herve, C. ;

Doffoel-Hantz, V. ;

Meyer, N. ;

Bulai-Livideanu, C. ;

Viraben, R. ;

Maza, A. ;

Adoue, D. ;

Bedane, C. ;

Paul, C. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (10) :1238-1240

[8]

Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts [J].

Murrell, Dedee F. ;

Daniel, Benjamin S. ;

Joly, Pascal ;

Borradori, Luca ;

Amagai, Masayuki ;

Hashimoto, Takashi ;

Caux, Frederic ;

Marinovic, Branka ;

Sinha, Animesh A. ;

Hertl, Michael ;

Bernard, Philippe ;

Sirois, David ;

Cianchini, Giuseppe ;

Fairley, Janet A. ;

Jonkman, Marcel F. ;

Pandya, Amit G. ;

Rubenstein, David ;

Zillikens, Detlef ;

Payne, Aimee S. ;

Woodley, David ;

Zambruno, Giovanna ;

Aoki, Valeria ;

Pincelli, Carlo ;

Diaz, Luis ;

Hall, Russell P. ;

Meurer, Michael ;

Mascaro, Jose M., Jr. ;

Schmidt, Enno ;

Shimizu, Hiroshi ;

Zone, John ;

Swerlick, Robert ;

Mimouni, Daniel ;

Culton, Donna ;

Lipozencic, Jasna ;

Bince, Benjamin ;

Grando, Sergei A. ;

Bystryn, Jean-Claude ;

Werth, Victoria P. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (03) :479-485

[9]

Shetty S, 2013, J DRUGS DERMATOL, V12, P672